Monica Lodi

703 total citations
15 papers, 231 citations indexed

About

Monica Lodi is a scholar working on Psychiatry and Mental health, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Monica Lodi has authored 15 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Genetics and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Monica Lodi's work include Epilepsy research and treatment (9 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Monica Lodi is often cited by papers focused on Epilepsy research and treatment (9 papers), Genetics and Neurodevelopmental Disorders (4 papers) and Pharmacological Effects and Toxicity Studies (3 papers). Monica Lodi collaborates with scholars based in Italy, United States and Slovenia. Monica Lodi's co-authors include Antonino Romeo, Maurizio Viri, Emilio Russo, Pierangelo Veggiotti, Angela La Neve, Simona Sacchi, Gaetano Zaccara, Pasquale Striano, Simona Lattanzi and Margherita Santucci and has published in prestigious journals such as Epilepsia, Nephrology Dialysis Transplantation and Frontiers in Pharmacology.

In The Last Decade

Monica Lodi

14 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Monica Lodi Italy 10 113 67 62 42 40 15 231
Gianluca D’Onofrio Italy 8 85 0.8× 44 0.7× 24 0.4× 21 0.5× 33 0.8× 26 178
Mustafa Kömür Türkiye 11 119 1.1× 125 1.9× 26 0.4× 30 0.7× 15 0.4× 49 376
Leonor Cabral‐Lim Philippines 7 152 1.3× 103 1.5× 36 0.6× 27 0.6× 31 0.8× 14 239
Carmen Gómez‐Lado Spain 11 64 0.6× 67 1.0× 70 1.1× 55 1.3× 5 0.1× 31 223
Luca Zagaroli Italy 6 111 1.0× 76 1.1× 38 0.6× 44 1.0× 16 0.4× 13 201
Yasemin Topçu Türkiye 10 56 0.5× 54 0.8× 28 0.5× 70 1.7× 5 0.1× 38 262
Tal Gilboa Israel 10 68 0.6× 51 0.8× 26 0.4× 46 1.1× 15 0.4× 22 210
Line Sveberg Norway 6 208 1.8× 213 3.2× 27 0.4× 29 0.7× 7 0.2× 10 371
Hepsen Mine Serin Türkiye 10 102 0.9× 104 1.6× 28 0.5× 28 0.7× 3 0.1× 34 290
Michelle Kiley Australia 8 156 1.4× 95 1.4× 12 0.2× 37 0.9× 13 0.3× 17 287

Countries citing papers authored by Monica Lodi

Since Specialization
Citations

This map shows the geographic impact of Monica Lodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monica Lodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monica Lodi more than expected).

Fields of papers citing papers by Monica Lodi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monica Lodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monica Lodi. The network helps show where Monica Lodi may publish in the future.

Co-authorship network of co-authors of Monica Lodi

This figure shows the co-authorship network connecting the top 25 collaborators of Monica Lodi. A scholar is included among the top collaborators of Monica Lodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monica Lodi. Monica Lodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Giorgis, Valentina De, Anna Tagliabue, Francesca Bisulli, et al.. (2023). Ketogenic dietary therapies in epilepsy: recommendations of the Italian League against Epilepsy Dietary Therapy Study Group. Frontiers in Neurology. 14. 1215618–1215618. 12 indexed citations
2.
Masnada, Silvia, et al.. (2023). Early Onset Paroxysmal Dyskinesia in PRRT2‐Related Disorders. Movement Disorders Clinical Practice. 10(4). 701–703.
3.
Contin, Manuela, et al.. (2021). Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program. Frontiers in Pharmacology. 12. 637801–637801. 26 indexed citations
4.
Pacetti, Mattia, Thea Giacomini, Massimo Cossu, et al.. (2021). Hemispheric surgery for severe epilepsy in early childhood: a case series. Epileptic Disorders. 23(4). 611–622. 2 indexed citations
6.
Lattanzi, Simona, Gaetano Zaccara, Emilio Russo, et al.. (2020). Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome. Expert Review of Neurotherapeutics. 21(1). 99–110. 28 indexed citations
7.
Romeo, Antonino, Monica Lodi, Maurizio Viri, et al.. (2014). Does the Co-occurrence of FGFR3 Gene Mutation in Hypochondroplasia, Medial Temporal Lobe Dysgenesis, and Focal Epilepsy Suggest a Syndrome?. Pediatric Neurology. 50(4). 427–430. 9 indexed citations
8.
Giordano, Lucio, Maurizio Viri, Renato Borgatti, et al.. (2012). Seizures and EEG patterns in Pallister–Killian syndrome: 13 New Italian patients. European Journal of Paediatric Neurology. 16(6). 636–641. 9 indexed citations
9.
Lodi, Monica, R. Chifari, Cecilia Parazzini, et al.. (2010). Seizures and EEG pattern in Kabuki syndrome. Brain and Development. 32(10). 829–834. 16 indexed citations
10.
Zucca, Claudio, Francesca Redaelli, Roberta Epifanio, et al.. (2008). Cryptogenic Epileptic Syndromes Related to SCN1A. Archives of Neurology. 65(4). 489–489. 33 indexed citations
11.
Romeo, Antonino, R. Chifari, Giuseppe Capovilla, et al.. (2008). Ictal impending danger – “sixth sense seizures” – in patients with benign focal epileptic seizures of adolescence. Epilepsy Research. 79(1). 90–96. 2 indexed citations
12.
Romeo, Antonino, et al.. (2007). Impact of Idiopathic Epilepsy on Mothers and Fathers: Strain, Burden of Care, Worries and Perception of Vulnerability. Epilepsia. 48(9). 1810–1814. 32 indexed citations
13.
Cimaz, Rolando, Antonino Romeo, Tadej Avčin, et al.. (2002). Prevalence of Anti‐cardiolipin, Anti‐β2 Glycoprotein I, and Anti‐prothrombin Antibodies in Young Patients with Epilepsy. Epilepsia. 43(1). 52–59. 39 indexed citations
14.
Viri, Maurizio, Rolando Cimaz, Monica Lodi, et al.. (1999). High prevalence of anticardiolipin and/or anti-beta2 glycoprotein i antibodies in young patients with epilepsy. The Italian Journal of Neurological Sciences. 20(5). 2 indexed citations
15.
Settefrati, N., et al.. (1996). Sjogren's syndrome associated with haemolytic-uraemic syndrome as the presenting clinical manifestation. Nephrology Dialysis Transplantation. 11(11). 2316–2319. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026